These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22143830)

  • 21. Evaluation of tumor-induced osteomalacia with 111In-pentetreotide scintigraphy.
    Palot Manzil FF; Bhambhvani PG; O'Malley JP
    J Nucl Med Technol; 2013 Dec; 41(4):299-301. PubMed ID: 24159011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor-induced osteomalacia: rhinosinusal hemangiopericytoma].
    Serafini EM; Pisarevsky AA; Plumet Garrido J; Zamora RJ; Petrucci EA
    Medicina (B Aires); 2013; 73(1):39-42. PubMed ID: 23335705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and radiologic characteristics of craniomaxillofacial primary tumor induced osteomalacia: a retrospective analysis].
    Wang M; Zhou L; Xue HD; Jiang Y; Zhong DR; Zhu ZH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Jun; 51(6):341-5. PubMed ID: 27256527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Findings on Bone Scintigraphy in Patients With Suspected Tumor-Induced Osteomalacia Should Not Be Overlooked.
    Wang L; Zhang S; Jing H; Chen L; Wang Z; Li F
    Clin Nucl Med; 2018 Apr; 43(4):239-245. PubMed ID: 29504962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report.
    Obo T; Koriyama N; Tokito A; Ogiso K; Nishio Y
    J Med Case Rep; 2020 May; 14(1):56. PubMed ID: 32384911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone scan in tumor-induced osteomalacia.
    Lee HK; Sung WW; Solodnik P; Shimshi M
    J Nucl Med; 1995 Feb; 36(2):247-9. PubMed ID: 7830124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culprit Tumor as an Unexpected Extraosseous MDP Activity on Bone Scintigraphy in a Patient With Tumor-Induced Osteomalacia.
    Xia X; Shao F; Hu F; Gai Y; Lan X
    Clin Nucl Med; 2020 Jun; 45(6):492-494. PubMed ID: 32366790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse pain, hypophosphatemia, and a subcutaneous nodule.
    Dewitt CA; Collins MT; Cowen EW
    J Am Acad Dermatol; 2007 Sep; 57(3):509-12. PubMed ID: 17707153
    [No Abstract]   [Full Text] [Related]  

  • 30. A Patient of Tumour Induced Osteomalacia Undiagnosed for 11 years.
    Gokhale N; Gokhale Y; Mahajan P
    J Assoc Physicians India; 2018 Apr; 66(4):81-4. PubMed ID: 30347965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of intact FGF-23 in tumor tissue from patients with oncogenic osteomalacia.
    Mannstadt M; Lorente C; Jüppner H
    Clin Chem; 2008 Jul; 54(7):1252-4. PubMed ID: 18593970
    [No Abstract]   [Full Text] [Related]  

  • 32. Phosphaturic mesenchymal tumor: a case report.
    Nayak A; Sharma SG; Tandon N; Ray R
    Indian J Pathol Microbiol; 2004 Oct; 47(4):530-3. PubMed ID: 16295386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation.
    Tutton S; Olson E; King D; Shaker JL
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3421-5. PubMed ID: 22837186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
    Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I; Rajani R
    J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor induced osteomalacia.
    Ioakimidis DE; Dendrinos GK; Frangia KB; Babiolakis DN; Chilas GI; Lyberopoulos KL; Kontomerkos TK
    J Rheumatol; 1994 Jun; 21(6):1162-4. PubMed ID: 7932437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report. Tumour-induced osteomalacia in a patient with osseous haemangioma.
    Lui CY; Khoo R; Law TC; Chong SF
    Clin Radiol; 2002 Dec; 57(12):1125-7. PubMed ID: 12475540
    [No Abstract]   [Full Text] [Related]  

  • 40. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
    Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
    Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.